Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate

 

Latest News

Date posted: 2/25/2013

Patients who have suffered a blood clot injury after taking Yaz or Yasmin will get an update this week on the status of thousands of Yaz settlements paid by drug maker Bayer.

Bayer will release their 4th Quarter 2012 and full year financial information on February 28th, and DrugRisk will have updated information on Yaz lawsuits and settlements from that data the same day.

Safety organizations from the FDA to the New England Journal of Medicine and British Medical Journal have warned in recent years that contraceptives which contain the hormone drospirenone, such as Yaz and Yasmin, can dramatically increase the risk of blood clots.

Blood clots can lead to severe or even fatal conditions like stroke, DVT and pulmonary embolism.

The safety alerts and news that Bayer was forced by the FDA to add adequate blood clot warnings to labels and advertising set off a wave of litigation by those patients affected.

In Bayer’s last financial reports for 2012’s 3rd quarter, the company admitted they faced more than 12,000 lawsuits from patients alleging side effects like DVT and pulmonary embolism. The company also admitted they had paid nearly $750 million so far to settle around 3,500 cases.

With the amount of patients filing a Yaz lawsuit, they were consolidated to a special federal Multi-District Litigation court in Illinois. Lawyers are still helping those affected join in the litigation and recover settlements.

Now, the latest report due from Bayer this week will update the number cases they face, how much they have spent on settlements, and how many cases have been resolved.

This may provide insight into how long the current Yaz settlements will last and how long victims of blood clots have to file a claim.

If you or a loved one suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin, it is important to speak with a lawyer about your legal options.

DrugRisk cautions that patients should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

Contact us today for more information on the research, side effects and litigation news related to Yaz, or to speak with a lawyer.